Phase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial
Osawa, H, Shinozaki, E, Nakamura, M, Ohhara, Y, Shindo, Y, Shiozawa, M, Uetake, H, Matsumoto, H, Ureshino, N, Satake, H, Kobayashi, T, Suto, T, Kitano, S, Ohashi, Y, Uemura, K, Yamaguchi, K
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study
Nakazawa, J., Otsuka, T., Shimokawa, M., Koga, F., Ueda, Y., Otsu, S., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Shibuki, T., Shirakawa, T., Mitsugi, K., Nio, K., Ide, Y., Ureshino, N.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer
Oki, E, Samura, H, Okumura, H, Ohchi, T, Orita, H, Kobayashi, K, Kinjo, T, Mori, S, Touyama, T, Ohgaki, K, Kawanaka, H, Makiyama, A, Ureshino, N, Kotaka, M, Shimose, T, Saeki, H, Nishimaki, T, Baba, H, Maehara, Y
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study
Nio, K., Iguchi, H., Shimokawa, M., Shirakawa, T., Koga, F., Ueda, Y., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Shibuki, T., Ide, Y., Ureshino, N., Mizuta, T., Mitsugi, K., Otsuka, T.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
P-88 A multicenter analysis of the correlation between overall survival and progression-free survival and the number of chemotherapeutic key drugs used in patients with advanced/unresectable pancreatic cancer: Results from the NAPOLEON study
Shirakawa, T., Ueda, Y., Shimokawa, M., Koga, F., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Uneda, S., Yoshida, M., Shibuki, T., Nio, K., Ide, Y., Ureshino, N., Mitsugi, K., Otsuka, T.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
SO-1 Prognostic nomogram to predict overall survival in patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: Real-world results from the multicenter retrospective study (NAPOLEON study)
Shibuki, T., Mizuta, T., Shimokawa, M., Koga, F., Ueda, Y., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Mitsugi, K., Nio, K., Ide, Y., Ureshino, N., Shirakawa, T., Otsuka, T.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
PD-5 Impact of biliary drainage for unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel: Results from the NAPOLEON study
Honda, T., Takayuki, O., Shimokawa, M., Koga, F., Ueda, Y., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Shibuki, T., Nio, K., Ide, Y., Ureshino, N., Mitsugi, K., Otsuka, T., Shirakawa, T.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
Prognostic impact of the C-reactive protein/albumin ratio in advanced pancreatic cancer treated with GEM plus nab-PTX or FOLFIRINOX: Based on the results of a multicenter retrospective study (the NAPOLEON study)
Makiyama, A., Nakazawa, J., Otsuka, T., Shimokawa, M., Koga, F., Ueda, Y., Komori, A., Arima, S., Fukahori, M., Honda, T., Shibuki, T., Shirakawa, T., Nio, K., Ide, Y., Ureshino, N., Mitsugi, K.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
P-065A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study
Nakazawa, J, Otsuka, T, Shimokawa, M, Koga, F, Ueda, Y, Otsu, S, Arima, S, Fukahori, M, Makiyama, A, Taguchi, H, Honda, T, Shibuki, T, Shirakawa, T, Mitsugi, K, Nio, K, Ide, Y, Ureshino, N
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
493PInitial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer
Oki, E, Samura, H, Okumura, H, Ohchi, T, Orita, H, Kobayashi, K, Kinjo, T, Mori, S, Touyama, T, Ohgaki, K, Kawanaka, H, Makiyama, A, Ureshino, N, Kotaka, M, Shimose, T, Saeki, H, Nishimaki, T, Baba, H, Maehara, Y
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
481PPhase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial
Osawa, H, Shinozaki, E, Nakamura, M, Ohhara, Y, Shindo, Y, Shiozawa, M, Uetake, H, Matsumoto, H, Ureshino, N, Satake, H, Kobayashi, T, Suto, T, Kitano, S, Ohashi, Y, Uemura, K, Yamaguchi, K
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Development of a novel, fully-automated genotyping system: principle and applications
Suzuki, Shun-Ichi, Komori, Mariko, Hirai, Mitsuharu, Ureshino, Norio, Kimura, Shinya
Published in Sensors (03.12.2012)
Published in Sensors (03.12.2012)
Get full text
Journal Article
Book Review
Gemcitabine Plus Radiotherapy in Patients with Unresectable Locally Advanced Pancreatic Cancer
Otsuka, T., Kamachi, S., Akiyama, T., Fujimoto, M., Kawazoe, S., Ureshino, N., Watanabe, T.
Published in Annals of oncology (01.10.2012)
Published in Annals of oncology (01.10.2012)
Get full text
Journal Article
A noninvasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA
Nakamura, T., Sueoka-Aragane, N., Iwanaga, K., Sato, A., Komiya, K., Abe, T., Ureshino, N., Hayashi, S., Sueoka, E., Kimura, S.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article